Patent · US Active

Medical use of the radical scavenger and antioxidant alpha-1-microglobulin

US10350268B2 · kind B2 · utility

1Cited by

3References

28Claims

0Family size

Assignee

A1M PHARMA AB · SE

Inventors

Bo Åkerström · Lund, SE
Stefan Hansson · Karlstad, SE
Martin L. Olsson · Bjärred, SE
Magnus Gram · Oxie, SE

Key dates

Filing date	Jul 17, 2009
Grant date	Jul 16, 2019
Priority date	—
Expiry date	Sep 15, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P39/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Medical use of alpha-1-microglobulin (A1M) in the treatment or prophylaxis of diseases wherein oxidative stress is a responsible factor in the progress of the disease. Notably, the present invention relates to the medical use of alpha-1-microglobulin in the treatment or prophylaxis of diseases or conditions associated with the presences of free radicals and/or free haemoglobin in the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.